What goes up, must come down: treating the hypertensive emergency P. W. de LeeuwA. A. Kroon EDITORIAL Pages: 277 - 279
Assuming the worst may not be bad at all Carvedilol in heart failure treatment B. M. W. SchmidtC. P. JansonM. Wehling CLINICAL TRIAL Pages: 281 - 285
Monitoring of proteinuria in phase I studies in healthy male subjects G. LemmJ. KüppersJ. Kuhlmann CLINICAL TRIALS Pages: 287 - 294
A comparison of the antihypertensive efficacy and safety of felodipine IV and nifedipine IV in patients with hypertensive crisis or emergency not responding to oral nifedipine T. RislerR. BohmC. M. Erley PHARMACODYNAMICS Pages: 295 - 298
Effect of omeprazole and cimetidine on plasma aldosterone response to angiotensin II M. SasakiA. MaedaA. Fujimura PHARMACODYNAMICS Pages: 299 - 302
Effect of meal timing on the kinetic-dynamic profile of levodopa/carbidopa controlled is release in parkinsonian patients M. ContinR. RivaA. Baruzzi PHARMACODYNAMICS Pages: 303 - 308
Psychomotor performance: investigating the dose-response relationship for caffeine and theophylline in elderly volunteers C. A. BryantA. FarmerS. H. D. Jackson PHARMACODYNAMICS Pages: 309 - 313
A Bayesian neural network method for adverse drug reaction signal generation A. BateM. LindquistR. M. De Freitas PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 315 - 321
Loop diuretics in patients aged 75 years or older: general practitioners' assessment of indications and possibilities for withdrawal D. J. W. van KraaijR. W. M. M. JansenW. H. L. Hoefnagels PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 323 - 327
Increasing awareness of and behaviour towards periconceptional folic acid consumption in The Netherlands from 1994 to 1995 L. T. W. de Jong-van den BergH. E. K. de WalleM. C. Cornel PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 329 - 331
Prescription changes and drug costs at the Interface between primary and specialist care D. BijlE. Van SonderenF. M. Haaijer-Ruskamp PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 333 - 336
The effect of grapefruit juice on the pharmacokinetics of orally administered verapamil R. ZaidensteinV. DishiA. Golik PHARMACOKINETICS AND DISPOSITION Pages: 337 - 340
Pharmacokinetics and safety of candesartan cilexetil in subjects with normal and impaired liver function J. F. W. HoogkamerC. H. KleinbloesemE. Weidekamm PHARMACOKINETICS AND DISPOSITION Pages: 341 - 345
Pharmacokinetic alterations of quinapril during repeated treatment in elderly subjects M. SasakiA. MaedaA. Fujimura PHARMACOKINETICS AND DISPOSITION Pages: 347 - 349
Effect of dimethicone (polysilane gel) on the stereoselective pharmacokinetics of ketoprofen N. PresleF. LapicqueP. Netter PHARMACOKINETICS AND DISPOSITION Pages: 351 - 354
Tiagabine, a novel antiepileptic agent: lack of pharmacokinetic interaction with digoxin S. SnelJ. A. JansenP. N. M. van Heiningen PHARMACOKINETICS AND DISPOSITION Pages: 355 - 357
A model for the determination of carbamazepine clearance in children on mono- and polytherapy A. L. GrayJ. H. BothaR. Miller PHARMACOKINETICS AND DISPOSITION Pages: 359 - 362
The pharmacokinetics of lamivudine in patients with impaired hepatic function M. A. JohnsonJ. HorakP. Breuel PHARMACOKINETICS AND DISPOSITION Pages: 363 - 366
Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open-label single-dose and multiple-dose study M. WolztV. FabriziiH.-G. Eichler PHARMACOKINETICS AND DISPOSITION Pages: 367 - 373
